This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,403.84 firm-fixed-price contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical supply, with a completion date of January 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,008.35 firm fixed-price contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, with a period of performance through July 16, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,340.50 firm fixed-price contract provides ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, to support military healthcare programs. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical that serves as a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,127.50, is for the delivery of ABRYSVO ACT-O-VIALS medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, under a firm fixed-price contract with a ceiling value of $34,628.80. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed price of $8,063.70 and a completion date of October 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS" medical supplies. The order has a firm fixed price of $30,357.37 and a completion date of September 12, 2024. Amerisourcebergen, through its Corporate Office Division, is a key vendor for the DLA, holding an Indefinite Delivery Contract (IDC) valued up to $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,919.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with an ultimate completion date of November 29, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This firm-fixed-price delivery order, valued at $11,032.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, by June 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award, valued at $1,612.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a completion date of October 25, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...